RB1 and breast cancer: Studies conducted on promyelocytic leukemia and breast cancer cell lines suggested that dephosphorylation of RB1 during apoptosis could be necessary for its cleavage by caspases and consequent degradation, which would eliminate its antiapoptotic action and allow cells to undergo death in response to apoptotic stimuli, such as DNA damage [65, 67, 72, 73].